Health Care
Commentary
No, $900B in Medicaid Spending Is Not Making Americans Healthier
During his confirmation hearing, Robert F. Kennedy Jr., the incoming secretary of the Department of Health and Human Services, posed a key question about the nation’s largest health insurance program. “Do you think all that money, the $900 billion we’re sending to Medicaid every year, has made Americans healthy?” he ...
Sally C. Pipes
February 14, 2025
Commentary
Congress Eyes Regulating Drug Ads, It Won’t Mean Lower Prices
“Knowing what something costs before buying it is just common sense.” That’s how Sen. Chuck Grassley, R-Iowa, justified a bill he introduced in January to require drug companies to include a medicine’s list price in their advertisements. Unfortunately, his Drug-price Transparency for Consumers, or DTC, Act — co-sponsored by Sen. ...
Sally C. Pipes
February 12, 2025
Commentary
Obamacare insurers collect billions in taxpayer subsidies — just to deny claims
Democrats spent the last four years trying to expand Obamacare enrollment, largely by ramping up federal premium subsidies. However, the health coverage available through the exchanges often doesn’t do much good, as too many Obamacare enrollees discover when a medical bill comes due. Read the op-ed here.
Sally C. Pipes
February 11, 2025
Commentary
The World’s Medicine Chest
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live ...
Sally C. Pipes
February 10, 2025
Drug Innovation
Why Failure-to-Market Claims Are Preempted Under Federal Law
A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The ...
Richard A. Epstein and Benjamin Flowers
February 5, 2025
Commentary
Unaffordable Medicaid Means We Should Forget It
U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Sally C. Pipes
February 5, 2025
Book
Read the new book from Sally Pipes “The World’s Medicine Chest”
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Sally C. Pipes
February 4, 2025
Commentary
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
Sally C. Pipes
February 4, 2025
Commentary
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Sally C. Pipes
February 3, 2025
Commentary
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...
Sally C. Pipes
January 29, 2025
No, $900B in Medicaid Spending Is Not Making Americans Healthier
During his confirmation hearing, Robert F. Kennedy Jr., the incoming secretary of the Department of Health and Human Services, posed a key question about the nation’s largest health insurance program. “Do you think all that money, the $900 billion we’re sending to Medicaid every year, has made Americans healthy?” he ...
Congress Eyes Regulating Drug Ads, It Won’t Mean Lower Prices
“Knowing what something costs before buying it is just common sense.” That’s how Sen. Chuck Grassley, R-Iowa, justified a bill he introduced in January to require drug companies to include a medicine’s list price in their advertisements. Unfortunately, his Drug-price Transparency for Consumers, or DTC, Act — co-sponsored by Sen. ...
Obamacare insurers collect billions in taxpayer subsidies — just to deny claims
Democrats spent the last four years trying to expand Obamacare enrollment, largely by ramping up federal premium subsidies. However, the health coverage available through the exchanges often doesn’t do much good, as too many Obamacare enrollees discover when a medical bill comes due. Read the op-ed here.
The World’s Medicine Chest
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live ...
Why Failure-to-Market Claims Are Preempted Under Federal Law
A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The ...
Unaffordable Medicaid Means We Should Forget It
U.S. House Republicans recently released a list of proposals for slashing federal spending by as much as $5.7 trillion. A significant portion of the proposed savings — a whopping $2.3 trillion — would come from Medicaid. Progressives are decrying the GOP document as a heartless assault on an essential safety-net ...
Read the new book from Sally Pipes “The World’s Medicine Chest”
Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special ...
Insulin prices are falling due to market forces — no price caps required
California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private insurance. It’s a popular idea. But it may not be necessary. The cost of insulin has been falling due to market ...
The CFPB’s New Medical Debt Rule Will Do More Harm Than Good
The Biden administration issued a flurry of directives in its final days. One move in particular warrants closer inspection. On January 7, the Consumer Financial Protection Bureau finalized a rule barring medical debt from appearing on credit reports. According to the agency, the rule will wipe $49 billion in medical ...
Patients Pay Dearly for Biden’s Pricing Mess
On Jan. 17, just days before leaving office, the Biden administration announced the next 15 prescription drugs dispensed through Medicare Part D that will be subject to price controls on Jan. 1, 2027, under the terms of the Inflation Reduction Act. Among them is the blockbuster semaglutide, a prescription medication ...